ESCAP_All countries vs Kazakhstan: Prevalence of anaemia in women aged 15-49
ESCAP_All countries
33.39
in 2023
Kazakhstan
30.5
in 2023
ESCAP_All countries rank
63rd
Kazakhstan rank
66th
Prevalence of anaemia in women aged 15-49 over time
- ESCAP_All countries
- Kazakhstan
How they compare
ESCAP_All countries currently reports 33.39 against 30.5 in Kazakhstan, a difference of 2.89.
That makes ESCAP_All countries's figure about 1.1 times Kazakhstan's.
The two have swapped places 1 time across 24 shared years of data; in 2000 it was Kazakhstan ahead.
ESCAP_All countries ranks 63rd and Kazakhstan ranks 66th of 155 groups.
Across the 3 decades both report, ESCAP_All countries averaged higher in 2 and Kazakhstan in 1.
Head to head by decade
| Decade | ESCAP_All countries | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.85 | 30.99 | 0.1402 | Kazakhstan |
| 2010s | 30.77 | 29.12 | 1.65 | ESCAP_All countries |
| 2020s | 32.65 | 30 | 2.65 | ESCAP_All countries |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anaemia in women aged 15-49, ESCAP_All countries or Kazakhstan?
- ESCAP_All countries, at 33.39 against 30.5 in Kazakhstan as of 2023.
- What is the difference in prevalence of anaemia in women aged 15-49 between ESCAP_All countries and Kazakhstan?
- 2.89, with ESCAP_All countries ahead.
- How many years of comparable data are there for ESCAP_All countries and Kazakhstan?
- 24 years are reported by both, from 2000 to 2023.
- How do ESCAP_All countries and Kazakhstan rank globally for prevalence of anaemia in women aged 15-49?
- ESCAP_All countries ranks 63rd and Kazakhstan ranks 66th of 155 groups.
- Where does this data come from?
- UNICEF, published as Prevalence of anaemia in women aged 15-49 (Modeled Estimates). Statizoid refreshes it automatically from the source and publishes the full history for both places.